#Cattle Respiratory Vaccines Market Research | Explore Tumblr Posts and Blogs

novumtimes · 4 months

Text

Bird Flu Has Infected a Third U.S. Farmworker

A third farmworker in the United States has been found to be infected with bird flu, heightening concerns about an outbreak among dairy cattle first identified in March. The worker is the first in this outbreak to have respiratory symptoms, including a cough, sore throat and watery eyes, which generally increase the likelihood of transmission to other people, federal officials said on Thursday. The other two people had only severe eye infections, possibly because of exposure to contaminated milk. All three individuals had direct exposure to dairy cows, and so far none has spread the virus to other people, Dr. Nirav Shah, principal deputy director of the Centers for Disease Control and Prevention, said at a news briefing. That suggests that the virus, called H5N1, has not acquired the ability to spread among people and that the threat to the general public remains low, Dr. Shah said. “This newest case does not change the C.D.C.’s H5N1 influenza risk assessment level for the general public,” he added. “We should remain alert, not be alarmed.” But the case does highlight the ongoing risk to farm workers, Dr. Shah said: “Our top priority now across this response is protecting the health of farmworkers.” This case is the second in Michigan, but the individual worked on a different farm than did the worker diagnosed last week. All three infected people so far have been treated with the antiviral medication oseltamivir, sometimes marketed as Tamiflu, officials said. There were few other details available, disappointing some experts. “There is no excuse for the lack of testing, transparency and trust,” said Rick Bright, the chief executive of Bright Global Health, a consulting company that focuses on improving responses to public health emergencies. He noted that federal officials are “months behind sharing virus sequence data.” “This is how pandemics start,” he said. The identification of a third case is not surprising because farm workers interact closely with dairy cows, experts said. New flu viruses often provoke respiratory symptoms without further spread to other people, Dr. Shah said. This latest patient may have had different symptoms because of the exposure dose, a different exposure route, predisposing genetic or medical factors or a combination of those attributes, said Angela Rasmussen, a research scientist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan in Canada. Still, gaining more information about how the person was infected, and about whether the virus has evolved to infect people more readily, is crucial, she said. Genetic analysis of the virus infecting the worker may be difficult because the amount obtained from the patient was very low. “But every time the virus is able to replicate in a person, there is potential for the virus to adapt to humans and gain molecular features for replication in the respiratory tract and to spread person-to-person,” said Seema Lakdawala, a virologist at Emory University in Atlanta. Officials are monitoring about 350 people who may have been exposed, about 220 of them in Michigan alone. So far relatively few farmworkers, about 40, have consented to testing. The Agriculture Department announced on Thursday that it was setting aside $824 million in new funding to quickly detect cases in poultry and livestock. The department is also starting a voluntary program for producers to test bulk milk, enabling them to transport virus-free herds across state lines without having to test individual cows. Federal researchers have completed their analysis of 109 beef samples, and found virus in just one, reported last week, officials said at the briefing. Federal officials could be doing more to protect farm workers and the public, experts said. “Vaccines from the national stockpile should be released for veterinarians and dairy farm workers willing to take it,” Dr. Lakdawala said. “We have an opportunity to reduce human infections and we need to do it now.” Source link via The Novum Times

#The Novum Times

0 notes

jayanthitbrc · 9 months

Text

Global Veterinary Anti-infectives Market Analysis 2024 – Estimated Market Size And Key Drivers

The Veterinary Anti-infectives by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Veterinary Anti-infectives Market: https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

According to The Business Research Company’s Veterinary Anti-infectives, The veterinary anti-infectives market size has grown strongly in recent years. It will grow from $5.09 billion in 2023 to $5.58 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing pet ownership, prevalence of infectious diseases, advancements in veterinary medicine, rising awareness, government initiatives.

The veterinary anti-infectives market size is expected to see strong growth in the next few years. It will grow to $8.05 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to continued pet population growth, emerging zoonotic diseases, globalization of pet trade, increasing veterinary healthcare expenditure. Major trends in the forecast period include technological advancements, increasing adoption of biologicals, integration of telehealth in veterinary services, focus on natural and herbal alternatives, expansion of e-commerce in veterinary pharmaceuticals, collaborations and partnerships.

An increase in pet ownership is expected to propel the growth of the veterinary anti-infectives market going forward. Pet ownership refers to owning a dog, cat, or other domestic pet at home. Pet are being adopted as increasing number of the young population are considering them as part of their family, some owners are adopting them for their compassion, loyalty and the to prevent loneliness. For instance, in February 2023, according to Chewy Inc., a US-based online retailer of pet food and other pet-related products, in 2021, approximately 977,202 pets found homes through adoption in the United States, marking the highest adoption rate in the past six years at 61%. Therefore, an increase in pet ownership is driving the demand for veterinary anti-infectives market.

Get A Free Sample Of The Report (Includes Graphs And Tables): https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes 2) By Species Type: Livestock Animals, Companion Animals 3) By Mode Of Administration: Oral, Parenteral, Topical 4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Technological advancements are a key trend gaining popularity in the veterinary anti-infectives market. Major companies operating in the market are using advanced technologies to sustain their position in the veterinary anti-infectives market. For instance, in February 2021, Elanco Animal Health Incorporated, a US-based pharmaceutical company that manufactures drugs and vaccinations for pets and livestock launched Increxxa, the newly approved drug for livestock respiratory disease. Increxxa with its key ingredient being tulathromycin is delivered to the livestock in injection and targets the lungs' site of infection swiftly for fast action and a lengthy half-life, providing cattle more time to establish a strong defense. This product is designed for veterinary use and tulathromycin, the active ingredient in Increxxa, helps decrease the negative effects of bovine respiratory disease.

The veterinary anti-infectives market report table of contents includes:

Executive Summary

Market Characteristics

Market Trends And Strategies

Impact Of COVID-19

Market Size And Growth

Segmentation

Regional And Country Analysis . . .

Competitive Landscape And Company Profiles

Key Mergers And Acquisitions

Future Outlook and Potential Analysis

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: [email protected]

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

0 notes

decisionforsight · 3 years

Text

Global Bovine Respiratory Disease Treatment Market

Global Bovine Respiratory Disease Treatment Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030

Bovine respiratory disease (BRD) is the most common and costly disease attacking beef cattle in the world. It is a complex, bacterial infection that causes pneumonia in calves which can be fatal. Symptoms including such as high fever, nasal discharge, rapid and shallow breathing, coughing, diminished, or no appetite. It is not a contagious disease. For the treatment of the BRD, vaccines are available. The most commonly used vaccine for veterinary respiratory diseases is antimicrobial agents, Non-steroidal anti-inflammatory drugs (NSAIDs), mucolytic agents. Oral rehydration, fluids, Bronchodilators, and immunomodulators. The global bovine respiratory disease treatment market size valued USD 449 million in 2020 is expected to reach USD 3279.78 million growing with a CAGR of 22 % over the forecast period.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020209

Market Dynamics and Factors:

According to the study, the increasing consumption of beef and the rising population are the major factors that are driving the bovine respiratory disease treatment market. The increase in beef consumption is due to the rising population and increasing disposable income, across the globe. Bovine Respiratory Disease (BRD) has a negative impact on the dairy and beef industries, due to calf mortality, treatment expenses, and additional labor costs. Additionally, BRD adversely affects the reproductive performance, growth, and lifespan of cattle. Consequently, there is a huge necessity for bovine respiratory disease treatment market. Moreover, to meet, the increasing demand for beef, most of the countries in the world are expanding the production of cattle meat. The rising demand for beef, increased production, leads to the growing importance of bovine respiratory disease treatment market. There are certain difficulties that are associated with the diagnosis of the BRD. Animals suffering from BRD often show signs of depression, weight loss, cough, nasal discharge, high fever, increased respiratory rate, and abnormal pulmonary sound on auscultation. The presumptive diagnosis after a physical examination is difficult, owing to the similarities of clinical signs and variation of possible bacteria. Hence, the complex diagnostic procedure is controlled the bovine respiratory disease treatment market growth.

Market Segmentation:

Global Bovine Respiratory Disease Treatment Market – By Drug Type

Antibiotics

Vaccines

NSAIDs

Immunomodulators

Others

Global Bovine Respiratory Disease Treatment Market – By Disease Type

Upper Respiratory Tract Infections

Pneumonia

Diphtheria

Global Bovine Respiratory Disease Treatment Market – By Distribution Channel

Veterinary Hospitals

Veterinary Clinics

Private Veterinary Pharmacies

Veterinary Research Institutes

Online Pharmacies

Global Bovine Respiratory Disease Treatment Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020209

Geographic Analysis:

Among the regions, North America is dominated the market in 2019 by contributing the largest bovine respiratory disease treatment market share in terms of revenue, due to increasing awareness about diseases and its treatment, high consumption of beef, increasing production and export beef, and the presence of companies available for manufacturing vaccines for bovine respiratory diseases. Asia Pacific is anticipated to grow at a higher CAGR Around 8.2% during the forecast period. Because of the growing population in India and China.

Competitive Scenario:

The market key players operating in the bovine respiratory disease treatment industry are Bayer Corporation, Boehringer Ingelheim GmbH, Bimeda Animal Health, Elanco, Vetoquinol S.A., Merck & Co Inc., Zoetis Inc., Novartis Animal Health, Vibrac S.A., Ceva Sante Animale, and Bimeda Animal Health.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020209

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Bovine Respiratory Disease Treatment industry, although key threats, opportunities and disruptive technologies that could shape the Global Bovine Respiratory Disease Treatment Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Bovine Respiratory Disease Treatment Market most.

The data analysis present in the Global Bovine Respiratory Disease Treatment Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Bovine Respiratory Disease Treatment Market business.

The 2021 Annual Global Bovine Respiratory Disease Treatment Market offers:

100+ charts exploring and analysing the Global Bovine Respiratory Disease Treatment Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Bovine Respiratory Disease Treatment Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020209

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: [email protected]

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

0 notes

marrincostello · 4 years

Text

Coronavirus: Microsoft Teams crashes as millions work at home | Daily Mail Online

What is the coronavirus?

A coronavirus is a type of virus which can cause illness in animals and people. Viruses break into cells inside their host and use them to reproduce itself and disrupt the body's normal functions. Coronaviruses are named after the Latin word 'corona', which means crown, because they are encased by a spiked shell which resembles a royal crown.

The coronavirus from Wuhan is one which has never been seen before this outbreak. It has been named SARS-CoV-2 by the International Committee on Taxonomy of Viruses. The name stands for Severe Acute Respiratory Syndrome coronavirus 2.

Experts say the bug, which has killed around one in 50 patients since the outbreak began in December, is a 'sister' of the SARS illness which hit China in 2002, so has been named after it.

The disease that the virus causes has been named COVID-19, which stands for coronavirus disease 2019.

Dr Helena Maier, from the Pirbright Institute, said: 'Coronaviruses are a family of viruses that infect a wide range of different species including humans, cattle, pigs, chickens, dogs, cats and wild animals.

'Until this new coronavirus was identified, there were only six different coronaviruses known to infect humans. Four of these cause a mild common cold-type illness, but since 2002 there has been the emergence of two new coronaviruses that can infect humans and result in more severe disease (Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses).

'Coronaviruses are known to be able to occasionally jump from one species to another and that is what happened in the case of SARS, MERS and the new coronavirus. The animal origin of the new coronavirus is not yet known.'

The first human cases were publicly reported from the Chinese city of Wuhan, where approximately 11million people live, after medics first started publicly reporting infections on December 31.

By January 8, 59 suspected cases had been reported and seven people were in critical condition. Tests were developed for the new virus and recorded cases started to surge.

The first person died that week and, by January 16, two were dead and 41 cases were confirmed. The next day, scientists predicted that 1,700 people had become infected, possibly up to 7,000.

Where does the virus come from?

According to scientists, the virus almost certainly came from bats. Coronaviruses in general tend to originate in animals – the similar SARS and MERS viruses are believed to have originated in civet cats and camels, respectively.

The first cases of COVID-19 came from people visiting or working in a live animal market in Wuhan, which has since been closed down for investigation.

Although the market is officially a seafood market, other dead and living animals were being sold there, including wolf cubs, salamanders, snakes, peacocks, porcupines and camel meat.

A study by the Wuhan Institute of Virology, published in February 2020 in the scientific journal Nature, found that the genetic make-up virus samples found in patients in China is 96 per cent identical to a coronavirus they found in bats.

However, there were not many bats at the market so scientists say it was likely there was an animal which acted as a middle-man, contracting it from a bat before then transmitting it to a human. It has not yet been confirmed what type of animal this was.

Dr Michael Skinner, a virologist at Imperial College London, was not involved with the research but said: 'The discovery definitely places the origin of nCoV in bats in China.

'We still do not know whether another species served as an intermediate host to amplify the virus, and possibly even to bring it to the market, nor what species that host might have been.'

So far the fatalities are quite low. Why are health experts so worried about it?

Experts say the international community is concerned about the virus because so little is known about it and it appears to be spreading quickly.

It is similar to SARS, which infected 8,000 people and killed nearly 800 in an outbreak in Asia in 2003, in that it is a type of coronavirus which infects humans' lungs. It is less deadly than SARS, however, which killed around one in 10 people, compared to approximately one in 50 for COVID-19.

Another reason for concern is that nobody has any immunity to the virus because they've never encountered it before. This means it may be able to cause more damage than viruses we come across often, like the flu or common cold.

Speaking at a briefing in January, Oxford University professor, Dr Peter Horby, said: 'Novel viruses can spread much faster through the population than viruses which circulate all the time because we have no immunity to them.

'Most seasonal flu viruses have a case fatality rate of less than one in 1,000 people. Here we're talking about a virus where we don't understand fully the severity spectrum but it's possible the case fatality rate could be as high as two per cent.'

If the death rate is truly two per cent, that means two out of every 100 patients who get it will die.

'My feeling is it's lower,' Dr Horby added. 'We're probably missing this iceberg of milder cases. But that's the current circumstance we're in.

'Two per cent case fatality rate is comparable to the Spanish Flu pandemic in 1918 so it is a significant concern globally.'

How does the virus spread?

The illness can spread between people just through coughs and sneezes, making it an extremely contagious infection. And it may also spread even before someone has symptoms.

It is believed to travel in the saliva and even through water in the eyes, therefore close contact, kissing, and sharing cutlery or utensils are all risky. It can also live on surfaces, such as plastic and steel, for up to 72 hours, meaning people can catch it by touching contaminated surfaces.

Originally, people were thought to be catching it from a live animal market in Wuhan city. But cases soon began to emerge in people who had never been there, which forced medics to realise it was spreading from person to person.

What does the virus do to you? What are the symptoms?

Once someone has caught the COVID-19 virus it may take between two and 14 days, or even longer, for them to show any symptoms – but they may still be contagious during this time.

If and when they do become ill, typical signs include a runny nose, a cough, sore throat and a fever (high temperature). The vast majority of patients will recover from these without any issues, and many will need no medical help at all.

In a small group of patients, who seem mainly to be the elderly or those with long-term illnesses, it can lead to pneumonia. Pneumonia is an infection in which the insides of the lungs swell up and fill with fluid. It makes it increasingly difficult to breathe and, if left untreated, can be fatal and suffocate people.

Figures are showing that young children do not seem to be particularly badly affected by the virus, which they say is peculiar considering their susceptibility to flu, but it is not clear why.

What have genetic tests revealed about the virus?

Scientists in China have recorded the genetic sequences of around 19 strains of the virus and released them to experts working around the world.

This allows others to study them, develop tests and potentially look into treating the illness they cause.

Examinations have revealed the coronavirus did not change much – changing is known as mutating – much during the early stages of its spread.

However, the director-general of China's Center for Disease Control and Prevention, Gao Fu, said the virus was mutating and adapting as it spread through people.

This means efforts to study the virus and to potentially control it may be made extra difficult because the virus might look different every time scientists analyse it.

More study may be able to reveal whether the virus first infected a small number of people then change and spread from them, or whether there were various versions of the virus coming from animals which have developed separately.

How dangerous is the virus?

The virus has a death rate of around two per cent. This is a similar death rate to the Spanish Flu outbreak which, in 1918, went on to kill around 50million people.

Experts have been conflicted since the beginning of the outbreak about whether the true number of people who are infected is significantly higher than the official numbers of recorded cases. Some people are expected to have such mild symptoms that they never even realise they are ill unless they're tested, so only the more serious cases get discovered, making the death toll seem higher than it really is.

However, an investigation into government surveillance in China said it had found no reason to believe this was true.

Dr Bruce Aylward, a World Health Organization official who went on a mission to China, said there was no evidence that figures were only showing the tip of the iceberg, and said recording appeared to be accurate, Stat News reported.

Can the virus be cured?

The COVID-19 virus cannot be cured and it is proving difficult to contain.

Antibiotics do not work against viruses, so they are out of the question. Antiviral drugs can work, but the process of understanding a virus then developing and producing drugs to treat it would take years and huge amounts of money.

No vaccine exists for the coronavirus yet and it's not likely one will be developed in time to be of any use in this outbreak, for similar reasons to the above.

The National Institutes of Health in the US, and Baylor University in Waco, Texas, say they are working on a vaccine based on what they know about coronaviruses in general, using information from the SARS outbreak. But this may take a year or more to develop, according to Pharmaceutical Technology.

Currently, governments and health authorities are working to contain the virus and to care for patients who are sick and stop them infecting other people.

People who catch the illness are being quarantined in hospitals, where their symptoms can be treated and they will be away from the uninfected public.

And airports around the world are putting in place screening measures such as having doctors on-site, taking people's temperatures to check for fevers and using thermal screening to spot those who might be ill (infection causes a raised temperature).

However, it can take weeks for symptoms to appear, so there is only a small likelihood that patients will be spotted up in an airport.

Is this outbreak an epidemic or a pandemic?

The outbreak was declared a pandemic on March 11. A pandemic is defined by the World Health Organization as the 'worldwide spread of a new disease'.

Previously, the UN agency said most cases outside of Hubei had been 'spillover' from the epicentre, so the disease wasn't actually spreading actively around the world.

This content was originally published here.

0 notes

bangkokjacknews · 5 years

Text

What do we know about the DEADLY CORONAVIRUS?

WHAT DO WE KNOW ABOUT THE DEADLY #CORONAVIRUS IN CHINA? Someone who is infected with the Wuhan coronavirus can spread it with just a simple cough or a sneeze, scientists say. At least 213 people with the virus are now confirmed to have died and more than 9,900 have been infected in at least 21 countries and regions. But experts predict the true number of people with the disease could be 100,000, or even as high as 350,000 in Wuhan alone, as they warn it may kill as many as two in 100 cases. Here's what we know so far: What is the Wuhan coronavirus? A coronavirus is a type of virus which can cause illness in animals and people. Viruses break into cells inside their host and use them to reproduce itself and disrupt the body's normal functions. Coronaviruses are named after the Latin word 'corona', which means crown, because they are encased by a spiked shell which resembles a royal crown. The coronavirus from Wuhan is one which has never been seen before this outbreak. It is currently named 2019-nCoV, and does not have a more detailed name because so little is known about it. Dr Helena Maier, from the Pirbright Institute, said: 'Coronaviruses are a family of viruses that infect a wide range of different species including humans, cattle, pigs, chickens, dogs, cats and wild animals. 'Until this new coronavirus was identified, there were only six different coronaviruses known to infect humans. Four of these cause a mild common cold-type illness, but since 2002 there has been the emergence of two new coronaviruses that can infect humans and result in more severe disease (Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses). https://bangkokjack.com/2020/02/03/thai-doctors-coronavirus-break-through/ 'Coronaviruses are known to be able to occasionally jump from one species to another and that is what happened in the case of SARS, MERS and the new coronavirus. The animal origin of the new coronavirus is not yet known.' The first human cases were publicly reported from the Chinese city of Wuhan, where approximately 11million people live, after medics first started seeing infections on December 31. By January 8, 59 suspected cases had been reported and seven people were in critical condition. Tests were developed for the new virus and recorded cases started to surge. The first person died that week and, by January 16, two were dead and 41 cases were confirmed. The next day, scientists predicted that 1,700 people had become infected, possibly up to 7,000. Just a week after that, there had been more than 800 confirmed cases and those same scientists estimated that some 4,000 – possibly 9,700 – were infected in Wuhan alone. By that point, 26 people had died. By January 27, more than 2,800 people were confirmed to have been infected, 81 had died, and estimates of the total number of cases ranged from 100,000 to 350,000 in Wuhan alone. By January 29, the number of deaths had risen to 132 and cases were in excess of 6,000. Where does the virus come from? Nobody knows for sure. Coronaviruses in general tend to originate in animals – the similar SARS and MERS viruses are believed to have originated in civet cats and camels, respectively. The first cases of the virus in Wuhan came from people visiting or working in a live animal market in the city, which has since been closed down for investigation. Although the market is officially a seafood market, other dead and living animals were being sold there, including wolf cubs, salamanders, snakes, peacocks, porcupines and camel meat. Bats are a prime suspect – researchers at the Chinese Academy of Sciences said in a recent statement: 'The Wuhan coronavirus' natural host could be bats… but between bats and humans there may be an unknown intermediate.' And another scientific journal article has suggested the virus first infected snakes, which may then have transmitted it to people at the market in Wuhan. Peking University researchers analysed the genes of the coronavirus and said they most closely matched viruses which are known to affect snakes. They said: 'Results derived from our evolutionary analysis suggest for the first time that snake is the most probable wildlife animal reservoir for the 2019-nCoV,' in the Journal of Medical Virology. So far the fatalities are quite low. Why are health experts so worried about it? Experts say the international community is concerned about the virus because so little is known about it and it appears to be spreading quickly. It is similar to SARS, which infected 8,000 people and killed nearly 800 in an outbreak in Asia in 2003, in that it is a type of coronavirus which infects humans' lungs. Another reason for concern is that nobody has any immunity to the virus because they've never encountered it before. This means it may be able to cause more damage than viruses we come across often, like the flu or common cold. Speaking at a briefing in January, Oxford University professor, Dr Peter Horby, said: 'Novel viruses can spread much faster through the population than viruses which circulate all the time because we have no immunity to them. 'Most seasonal flu viruses have a case fatality rate of less than one in 1,000 people. Here we're talking about a virus where we don't understand fully the severity spectrum but it's possible the case fatality rate could be as high as two per cent.' If the death rate is truly two per cent, that means two out of every 100 patients who get it will die. 'My feeling is it's lower,' Dr Horby added. 'We're probably missing this iceberg of milder cases. But that's the current circumstance we're in. 'Two per cent case fatality rate is comparable to the Spanish Flu pandemic in 1918 so it is a significant concern globally.' How does the virus spread? The illness can spread between people just through coughs and sneezes, making it an extremely contagious infection. And it may also spread even before someone has symptoms. It is believed to travel in the saliva and even through water in the eyes, therefore close contact, kissing, and sharing cutlery or utensils are all risky. Originally, people were thought to be catching it from a live animal market in Wuhan city. But cases soon began to emerge in people who had never been there, which forced medics to realise it was spreading from person to person. There is now evidence that it can spread third hand – to someone from a person who caught it from another person. What does the virus do to you? What are the symptoms? Once someone has caught the virus it may take between two and 14 days for them to show any symptoms – but they may still be contagious during this time. If and when they do become ill, typical signs include a runny nose, a cough, sore throat and a fever (high temperature). The vast majority of patients – at least 97 per cent, based on available data – will recover from these without any issues or medical help. In a small group of patients, who seem mainly to be the elderly or those with long-term illnesses, it can lead to pneumonia. Pneumonia is an infection in which the insides of the lungs swell up and fill with fluid. It makes it increasingly difficult to breathe and, if left untreated, can be fatal and suffocate people. What have genetic tests revealed about the virus? Scientists in China have recorded the genetic sequences of around 19 strains of the virus and released them to experts working around the world. This allows others to study them, develop tests and potentially look into treating the illness they cause. Examinations have revealed the coronavirus did not change much – changing is known as mutating – much during the early stages of its spread. However, the director-general of China's Center for Disease Control and Prevention, Gao Fu, yesterday said the virus was mutating and adapting as it spread through people. This means efforts to study the virus and to potentially control it may be made extra difficult because the virus might look different every time scientists analyse it. More study may be able to reveal whether the virus first infected a small number of people then change and spread from them, or whether there were various versions of the virus coming from animals which have developed separately. How dangerous is the virus? The virus has so far killed 213 people out of a total of at least 9,800 officially confirmed cases – a death rate of around two per cent. This is a similar death rate to the Spanish Flu outbreak which, in 1918, went on to kill around 50million people. However, experts say the true number of patients is likely considerably higher and therefore the death rate considerably lower. Imperial College London researchers estimate that there were 4,000 (up to 9,700) cases in Wuhan city alone up to January 18 – officially there were only 444 there to date. If cases are in fact 100 times more common than the official figures, the virus may be far less dangerous than currently believed. Experts say it is likely only the most seriously ill patients are seeking help and are therefore recorded – the vast majority will have only mild, cold-like symptoms. For those whose conditions do become more severe, there is a risk of developing pneumonia which can destroy the lungs and kill you. Can the virus be cured? The Wuhan coronavirus cannot currently be cured and it is proving difficult to contain. Antibiotics do not work against viruses, so they are out of the question. Antiviral drugs can, but the process of understanding a virus then developing and producing drugs to treat it would take years and huge amounts of money. No vaccine exists for the coronavirus yet and it's not likely one will be developed in time to be of any use in this outbreak, for similar reasons to the above. The National Institutes of Health in the US, and Baylor University in Waco, Texas, say they are working on a vaccine based on what they know about coronaviruses in general, using information from the SARS outbreak. But this may take a year or more to develop, according to Pharmaceutical Technology. Currently, governments and health authorities are working to contain the virus and to care for patients who are sick and stop them infecting other people. People who catch the illness are being quarantined in hospitals, where their symptoms can be treated and they will be away from the uninfected public. And airports around the world are putting in place screening measures such as having doctors on-site, taking people's temperatures to check for fevers and using thermal screening to spot those who might be ill (infection causes a raised temperature). However, it can take weeks for symptoms to appear, so there is only a small likelihood that patients will be spotted up in an airport. Is this outbreak an epidemic or a pandemic? The outbreak has not officially been confirmed as either an epidemic or a pandemic yet. This is likely because, despite the global concern, the number of people who have been confirmed to be infected is still relatively low. A pandemic is defined by the World Health Organization as the 'worldwide spread of a new disease'. An epidemic is when a disease takes hold of a smaller community, such as a single country, region or continent. – You can follow BangkokJack on Instagram, Twitter & Reddit. Or join the free mailing list (top right) Please help us continue to bring the REAL NEWS - PayPal Read the full article

0 notes

rootindiahealthcare · 5 years

Text

Coronavirus Outbreak: Symptoms & Complications

January 24, 2020 - News about the outbreak of coronavirus that began in Wuhan, China is changing rapidly. Respiratory infection, which is closely associated with SARS; and MERS, is spreading throughout China, and cases have been diagnosed in several other countries, including the United States. We provide cases, deaths, travel restrictions and other latest updates here. What's the latest news? On 29/Jan/2020, Wednesday, CDC medical officials and others met with a group of about 210 US citizens abandoned from China. His plane landed at California's March Air Reserve Base, where an evacuation would be monitored for several days for coronavirus symptoms. Anyone showing signs of the disease; will be taken to the hospital. Some airlines, including British Airways and United Airlines, are halting or reducing flights to China as the number of cases is increasing rapidly. According to the European Center for Disease Prevention and Control. There are now more than 6,000 cases and 132 deaths worldwide. While the majority of cases are in China. It has been found in the US and these countries: Thailand, Hong Kong, Taiwan, Australia, Macau, Singapore, Japan, South Korea, Malaysia, France, Canada, Vietnam, Nepal, Cambodia, Germany, and the United Arab Emirates Emirates. There have been no deaths outside China. USA Alert In the US, the CDC is listing five confirmed cases from these states: Illinois, California, Washington, and Arizona. On Monday, Jan-27-2020, Nancy Massonier, MD, the agency's director of national immunization and respiratory diseases, said it had 165 individuals from 36 states under investigation for coronavirus. In addition to 5 confirmed positives, 68 have tested negative. They are prioritizing testing based on an individual's risk. Massonier said he had posted the blueprint of his clinical trial to a public server and was working "as soon as possible" to bring the test kit to the states. Right now all testing for the new coronavirus is being done at the CDC headquarters in Atlanta. She said the CDC is making changes to its travel screening for infection but did not provide further details. How many people have been treated with the virus? and how many have expired? According to the European CDC, the majority of confirmed cases - 5,994 - are in China. 78 other cases have been confirmed in 16 countries outside China. The most confirmed countries include Thailand with 14 and Taiwan and South Korea with 8. All reported deaths have occurred in China, and include 16 health workers. When did its outbreak begin? China first reported an outbreak in Wuhan on December 30, 2019. What are public officials doing to stop the virus? On Tuesday, the CDC urged passengers to avoid non-essential travel to China. Chinese authorities have shut down all public transport in 10 cities, affecting 35 million people. The first was Wuhan, which had a population of about 11 million. Wuhan, which includes buses, subways, trains, and airports. All passengers flying from Wuhan to the United States will be routed through one of the five airports; and screened for fever and other symptoms of the virus. “Concern patients will be sent to a facility and given a test to find out if they have the virus. What do we know about cases in the United States? In all of the US, cases reported so far, patients had recently traveled to Wuhan. There are two patients in California, one in Los Angeles County and one in Orange County. The Orange County patient is a man in his 50s. According to the Orange County Health Care Agency, she is in a local hospital in isolation and is in good condition. Los Angeles County officials did not provide additional information about the patient there. Arizona's Department of Health Services said its patient is a resident of Maricopa County and a member of the Arizona State University community that did not live in student housing. The patient is not seriously ill and is being kept in isolation. #Chicago Another case involves a 60s-old woman from Chicago. The Chicago Department of Public Health reported that he visited Wuhan, China in December and returned to Chicago earlier this month. He is hospitalized in stable condition. A first American patient is a man in his 30s from Washington state. He had traveled from Wuhan and entered the country before the screening. And He started having symptoms and contacted his doctor. He is in good health and is in quarantine at Providence Regional Medical Center. Is travel to China safe? Wuhan is closed to travelers. The CDC is advising travelers to avoid non-essential travel to China. Passengers required to: Avoid contact with sick people. Avoid animals, animal markets and animal products. Wash your hands often with soap and water, or use an alcohol-based sanitizer if it is not available. Seek immediate medical care for fever, cough or difficulty in breathing. Tell a health care professional about any visit. What are the symptoms, and how is the virus treated further? China performed a test for the virus and shared that information with other nations. The CDC has developed its own test. Symptoms include fever, cough, and shortness of breath. They can appear 2 to 14 days after you are exposed to the virus. What is the cause of the virus, and how does it develop? Health officials are not yet sure of the source of the virus or how easily it can spread. Coronaviruses are discovered in many different animals, including cattle, cats, camels, and bats. A research paper also suggested snakes as a possible source. The new virus may be linked to seafood and live animal market in Wuhan; that has since closed The virus can spread from one infected person to another healthy person. Health officials are seeing this most often where people are close together and in healthcare settings. 16 health care workers have been infected as yet. The CDC believes that severe acute respiratory syndrome (SARS); and the Middle East respiratory syndrome (MERS), two other types of coronavirus; are spread by droplets when someone coughs or sneezes. Is there a comment? There is no vaccine, but the National Institutes of Health is working on one; and the trial is expected to begin in several months. This test will be for safety. If it is safe, then there will be tests to see how well it works. How is it treated? There is no specific treatment for the virus. The Patients are usually given supportive care for their symptoms; such as fluids and pain relievers. Hospitalized patients may require breathing assistance. Read the full article

0 notes

vinayakmrfr1998-blog · 4 years

Text

Animal Health Market Size, Growth, Trends, Regional Factors and Analysis Under Global Industrial Research Forecast Till 2023

Animal Health Market: Information by Animal Type (Farm animal, Companion animal), Product (Pharmaceuticals, Vaccines, Feed Additives), Route of Administration (Oral, Parenteral), Distribution Channel (Retail, E-Commerce) — Global Forecast till 2023

Animal health is a branch of medicine catering to the welfare of companion and farm animals. It is vital in preventing the propagation of infectious diseases to animals, which in turn can affect humans. Continuous monitoring of animals is a prime aspect of animal health. The global animal health market report by Market Research Future (MRFR) contains an analytical perspective on numerous trends, opportunities, drivers, and restraints to be faced by manufacturers creating medicines and drugs for the period of 2018 to 2023 (forecast period).

Market Scope

The global animal health market is projected to exhibit 5.7% over the forecast period. It can be driven by the outbreak of infectious diseases affecting animals in recent years. For instance, porcine reproductive and respiratory syndrome (PRRS) had costs farmers in the U.S. close to USD 600 million. Deterioration of animal health can negatively economic growth of nations and overall stability of the agricultural sector. The market had stood at a value of USD 38,500 million in 2017.

Free Sample Report At:

https://www.marketresearchfuture.com/sample_request/7163

Rise of zoonotic diseases, inflated spending on animal health, rising adoption numbers of pets, and growing pet insurance are major factors expected to drive market growth. Scientists suggest that 6 out of 10 infectious diseases affecting humans have the probability of coming from animals, according to the Center of Disease Control & Prevention (CDC). Government programs supporting veterinarians, scientists, and farmers in their fight against tackling infectious diseases is expected to work favorably for the market.

But high costs associated with animal health and lack of veterinary services in underdeveloped services can hamper market growth.

Segmentation

The global animal health market is segmented by animal type, product, route of administration, and distribution channel.

By animal type, the market caters to farm animal and companion animal. The farm animal segment has been further segmented into sheep & goats, poultry, swine, cattle, and others. While the companion animal segment has been further classified into equine, dog, cat, and others. Among the two, the farm animal segment is expected to hold the largest market share of the animal health market till the end of the forecast period.

Products include feed additives, pharmaceuticals, and vaccines. Pharmaceuticals are further sub-segmented into anti-inflammatory, parasiticides, anti-infectives, analgesics, and others. While, the vaccines segment is further split into recombinant vaccines, live attenuated vaccines, inactivated vaccines, DNA vaccines, and others. The vaccines segment to register the highest CAGR in the global animal health market during the forecast period.

Based on route of administration, the market has been segmented into topical, oral, parenteral, and others.

Distribution channels discussed in the global animal health market include e-commerce, veterinary hospitals & clinics, retail, and others.

Regional Analysis

Geographically, the market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas can dominate the global animal health market till 2024 owing to heightened demand for advanced veterinary services. Focus on animal safety, demand for animal protein, medication of pets, and adoptions of pets from shelters are major drivers of the market. According to the American Pet Products Manufacturing Association (APPA), nearly 80% of pets in the U.S. are treated with drugs.

APAC is projected to display the fastest growth rate during the forecast period owing to rise in animal welfare programs and the growth in the population of animal welfare programs. India and China are countries expected to contribute to regional market growth.

Competitive Outlook

Eli Lilly, Virbac, Zoetis, Elanco, Vetiquinol SA, Merck Animal Health, Boehringer Ingelheim GmbH, Ceva Sante Animale, Bayer AG, and Nutreco N.V. are top animal health companies profiled in the market report. Players are focusing on innovations which can expand the scope of the future of animal health.

Browser Complete Report At:

https://www.marketresearchfuture.com/reports/animal-health-market-7163

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]

#Animal Health Market #Animal Health Market Growth #Animal Health Market Trends #Animal Health Market Research #Animal Health Market Size #Animal Health Market Share

0 notes

quicklovesolutions-blog · 5 years

Text

Things to Know About Coronavirus, Its Symptoms And Its Prevention

Coronavirus is a group of viruses mainly found in mammals which includes Human also and it became the trending topic for NEWS headlines as many people are getting infected by this virus and hundreds of people from different countries has already lost their lives. China has got huge impact because of this virus, people are getting locked to their homes and buildings by the officials just not to spread this virus. People who are infected by this virus are not allowed to visit their families even doctors who are involve in the rescue operations has also lost their life. People from other countries who went to china for some reasons, are appealing to their respective governments to accept them back to their country. But, as this virus spread very easily and due to lack of treatment available in the world, countries are hesitating to bring the citizen back. The most important fact about this is till now no vaccine or exact treatment available to overcome this dangerous virus. In this articles I am going to share few facts about this virus.

This virus mainly found in mammals which includes Human and birds as well. It mainly found in animals such as cows, pigs and chickens and the animal carrying Coronavirus shows symptoms like diarrhea and upper respiratory diseases and there is no drug or vaccine available for its prevention.

Facts:

SARS and MERS are the two dangerous disease that can be caused by Coronavirus. In research, it is found that this virus can infect mice, rats, dogs, cats, pigs and cattles. This viruses are responsible for about 30% of common colds and there are six known human coronaviruses. SARS (Sever acute respiratory syndrome) spread from China to other nearby countries like Singapore and killed almost 774 or more peoples. There is no vaccine available for the common cold by Coronavirus. Human Coronavirus

Human Coronavirus first found in 1960's in the noses of patient with common cold.

Coronavirus were given their name because of its crown like projection on its surface and corona in "Latin" means "Halo" or "Crown".

Coronavirus antibodies do not last for a very long time. In humans, this infection most often occurs during the month of winters as well as rainy.

Symptoms

Human infected with this virus can be found with the following symptoms.

Cold or flu type symptoms Fever Running nose Sneezing Sore throat Fatigue Asthma Any respiratory disorder Things to be taken care

As these virus has no particular vaccine or drug available in the market following things has to be taken care of so to prevent these virus from spreading.

Drink enough water (boiled) Avoid smoking Avoid going to public places, if necessary then carry mask Use clean cloth to stop running nose or while sneezing Take rest and avoid overexertion If found any symptomes then consult direct to the doctor If you traveled recently internationally and find any symptoms then consult your doctor and tell then about this before visiting them. As always said, prevention is better than cure, so we need to be aware about such health problems. I wish all of you to be aware and stay healthy.

vashikaran for husband

black magic specialist

relationship problem solution

best vashikaran specialist astrologer

best tantrik

other caste love marriage specialist baba

muslim love vashikaran

kala jadu vashikaran

vashikaran for girl

vashikaran for wife

vashikaran mantra

vashikaran specialist

love marriage specialist

get your love back

divorce problem solution

online vashikaran

love problem solution

husband wife problem solution

vashikaran for boy

family problem solution

vashikaran specialist in delhi

famous astrologer in India

real vashikaran specialist

sabar mantra specialist

true vashikaran specialist

vashikaran astrologer

vashikaran baba

vashikaran specialist near me

vashikaran tantrik

Love Problem Solution in Delhi

Love Problem Solution in Mumbai

Love Problem Solution in Bangalore

Love Problem Solution in Pune

Love Problem Solution in Hyderabad

Love Problem Solution in Bhopal

Love Problem Solution in Kolkata

Love Problem Solution in Bhubaneswar

Love Problem Solution in Guwahati

Love Problem Solution in Lucknow

#love problem solution #best astrologer #vashikaran specialist #mohini mantra specialist #red book specialist #gem stones specialist #black magic specialist

0 notes

alicecpacheco · 5 years

Text

Covid-19 Information from the Centers for Disease Control and Prevention

As focus increases more and more on the Cover-19 virus, the world is, unfortunately, awash is poor information, misinformation, and straight out lies.

Scammers are no using people’s fears to fleece them of huge amounts of money. Global panic has ensued. Reason has taken a backseat to information such as “well I heard…”.

With those types of situations going on, it is difficult to sort out science from fiction or manipulation. Trust me when I say the only way we are going to effectively deal with this is with science and reason. That all stars with knowing where to find good, scientific, and reliable information. For today’s post I’d like to give you the most recent information from the CDC (Centers for Disease Control and Prevention). Any time that you need the most current information on Covid-19, this link will take you to the CDC webpage with the most current Situation Summary.

Here is what they have to say currently:

Background

CDC is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus that was first detected in China and which has now been detected in more than 100 locations internationally, including in the United States. The virus has been named “SARS-CoV-2” and the disease it causes has been named “coronavirus disease 2019” (abbreviated “COVID-19”).

On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organization (WHO) declared the outbreak a “public health emergency of international concernexternal icon” (PHEIC). On January 31, Health and Human Services Secretary Alex M. Azar II declared a public health emergency (PHE) for the United States to aid the nation’s healthcare community in responding to COVID-19. On March 11, WHO publiclyexternal icon characterized COVID-19 as a pandemic. On March 13, the President of the United States declared the COVID-19 outbreak a national emergencyexternal icon.

Source and Spread of the Virus

Coronaviruses are a large family of viruses that are common in people and many different species of animals, including camels, cattle, cats, and bats. Rarely, animal coronaviruses can infect people and then spread between people such as with MERS-CoV, SARS-CoV, and now with this new virus (named SARS-CoV-2).

The SARS-CoV-2 virus is a betacoronavirus, like MERS-CoV and SARS-CoV. All three of these viruses have their origins in bats. The sequences from U.S. patients are similar to the one that China initially posted, suggesting a likely single, recent emergence of this virus from an animal reservoir.

Early on, many of the patients at the epicenter of the outbreak in Wuhan, Hubei Province, China had some link to a large seafood and live animal market, suggesting animal-to-person spread. Later, a growing number of patients reportedly did not have exposure to animal markets, indicating person-to-person spread. Person-to-person spread was subsequently reported outside Hubei and in countries outside China, including in the United States. Some international destinations now have ongoing community spread with the virus that causes COVID-19, as do some parts of the United States. Community spread means some people have been infected and it is not known how or where they became exposed. Learn what is known about the spread of this newly emerged coronaviruses.

Severity

The complete clinical picture with regard to COVID-19 is not fully known. Reported illnesses have ranged from very mild (including some with no reported symptoms) to severe, including illness resulting in death. While information so far suggests that most COVID-19 illness is mild, a reportexternal icon out of China suggests serious illness occurs in 16% of cases. Older people and people of all ages with severe chronic medical conditions — like heart disease, lung disease and diabetes, for example — seem to be at higher risk of developing serious COVID-19 illness.

Learn more about the symptoms associated with COVID-19.

COVID-19 Now a Pandemic

A pandemic is a global outbreak of disease. Pandemics happen when a new virus emerges to infect people and can spread between people sustainably. Because there is little to no pre-existing immunity against the new virus, it spreads worldwide.

The virus that causes COVID-19 is infecting people and spreading easily from person-to-person. Cases have been detected in most countries worldwide and community spread is being detected in a growing number of countries. On March 11, the COVID-19 outbreak was characterized as a pandemic by the WHOexternal icon.

This is the first pandemic known to be caused by the emergence of a new coronavirus. In the past century, there have been four pandemics caused by the emergence of novel influenza viruses. As a result, most research and guidance around pandemics is specific to influenza, but the same premises can be applied to the current COVID-19 pandemic. Pandemics of respiratory disease follow a certain progression outlined in a “Pandemic Intervals Framework.” Pandemics begin with an investigation phase, followed by recognition, initiation, and acceleration phases. The peak of illnesses occurs at the end of the acceleration phase, which is followed by a deceleration phase, during which there is a decrease in illnesses. Different countries can be in different phases of the pandemic at any point in time and different parts of the same country can also be in different phases of a pandemic.

There are ongoing investigations to learn more. This is a rapidly evolving situation and information will be updated as it becomes available.

Situation in U.S.

Different parts of the country are seeing different levels of COVID-19 activity. The United States nationally is currently in the initiation phases, but states where community spread is occurring are in the acceleration phase. The duration and severity of each phase can vary depending on the characteristics of the virus and the public health response.

CDC and state and local public health laboratories are testing for the virus that causes COVID-19. View CDC’s Public Health Laboratory Testing map.

More and more states are reporting cases of COVID-19 to CDC.

U.S. COVID-19 cases include:

Imported cases in travelers

Cases among close contacts of a known case

Community-acquired cases where the source of the infection is unknown.

Three U.S. states are experiencing sustained community spread.

View latest case counts, deaths, and a map of states with reported cases.

Risk Assessment

Risk depends on characteristics of the virus, including how well it spreads between people; the severity of resulting illness; and the medical or other measures available to control the impact of the virus (for example, vaccines or medications that can treat the illness) and the relative success of these. In the absence of vaccine or treatment medications, nonpharmaceutical interventions become the most important response strategy. These are community interventions that can reduce the impact of disease.

The risk from COVID-19 to Americans can be broken down into risk of exposure versus risk of serious illness and death.

Risk of exposure:

The immediate risk of being exposed to this virus is still low for most Americans, but as the outbreak expands, that risk will increase. Cases of COVID-19 and instances of community spread are being reported in a growing number of states.

People in places where ongoing community spread of the virus that causes COVID-19 has been reported are at elevated risk of exposure, with the level of risk dependent on the location.

Healthcare workers caring for patients with COVID-19 are at elevated risk of exposure.

Close contacts of persons with COVID-19 also are at elevated risk of exposure.

Travelers returning from affected international locations where community spread is occurring also are at elevated risk of exposure, with level of risk dependent on where they traveled.

Risk of Severe Illness:

Early information out of China, where COVID-19 first started, shows that some people are at higher risk of getting very sick from this illness. This includes:

Older adults, with risk increasing by age.

People who have serious chronic medical conditions like:

Heart disease

Diabetes

Lung disease

CDC has developed guidance to help in the risk assessment and management of people with potential exposures to COVID-19.

What May Happen

More cases of COVID-19 are likely to be identified in the United States in the coming days, including more instances of community spread. CDC expects that widespread transmission of COVID-19 in the United States will occur. In the coming months, most of the U.S. population will be exposed to this virus.

Widespread transmission of COVID-19 could translate into large numbers of people needing medical care at the same time. Schools, childcare centers, and workplaces, may experience more absenteeism. Mass gatherings may be sparsely attended or postponed. Public health and healthcare systems may become overloaded, with elevated rates of hospitalizations and deaths. Other critical infrastructure, such as law enforcement, emergency medical services, and sectors of the transportation industry may also be affected. Healthcare providers and hospitals may be overwhelmed. At this time, there is no vaccine to protect against COVID-19 and no medications approved to treat it. Nonpharmaceutical interventions will be the most important response strategy to try to delay the spread of the virus and reduce the impact of disease.

CDC Response

Global efforts at this time are focused concurrently on lessening the spread and impact of this virus. The federal government is working closely with state, local, tribal, and territorial partners, as well as public health partners, to respond to this public health threat.

CDC is implementing its pandemic preparedness and response plans, working on multiple fronts, including providing specific guidance on measures to prepare communities to respond to local spread of the virus that causes COVID-19. There is an abundance of pandemic guidance developed in anticipation of an influenza pandemic that is being adapted for a potential COVID-19 pandemic.

Highlights of CDC’s Response

CDC established a COVID-19 Incident Management System on January 7, 2020. On January 21, CDC activated its Emergency Operations Center to better provide ongoing support to the COVID-19 response.

The U.S. government has taken unprecedented steps with respect to travel in response to the growing public health threat posed by this new coronavirus:

Foreign nationals who have been in China or Iran within the past 14 days cannot enter the United States.

U.S. citizens, residents, and their immediate family members who have been in China or Iran within in the past 14 days can enter the United States, but they are subject to health monitoring and possible quarantine for up to 14 days.

On March 11external icon, a similar policy was expanded to include 26 European countries for a period of 30 days.

On March 8, CDC recommended that people at higher risk of serious COVID-19 illness avoid cruise travel and non-essential air travel.

Additionally, CDC has issued the following additional specific travel guidance related to COVID-19.

CDC has issued clinical guidance, including:

On January 30, CDC published guidance for healthcare professionals on the clinical care of COVID-19 patients.

On February 3, CDC posted guidance for assessing the potential risk for various exposures to COVID-19 and managing those people appropriately.

On February 27, CDC updated its criteria to guide evaluation of persons under investigation for COVID-19.

On March 8, CDC issued a Health Alert Network (HAN).

On March 10, CDC issued updated infection control guidance for healthcare settings, including guidance on the use of personal protective equipment (PPE) during a shortage.

CDC has deployed multidisciplinary teams to support state health departments case identification, contact tracing, clinical management, and public communications.

CDC has worked with federal partners to support the safe return of Americans overseas who have been affected by COVID-19.

An important part of CDC’s role during a public health emergency is to develop a test for the pathogen and equip state and local public health labs with testing capacity.

CDC developed an rRT-PCR test to diagnose COVID-19.

As of the evening of March 10, 79 state and local public health labs in 50 states and the District of Columbia have successfully verified and are currently using CDC COVID-19 diagnostic tests.

Combined with other reagents that CDC has procured, there are enough testing kits to test more than 75,000 people.

In addition, CDC has two laboratories conducting testing for the virus that causes COVID-19. CDC can test approximately 350 specimens per day.

Commercial labs are working to develop their own tests that hopefully will be available soon. This will allow a greater number of tests to happen close to where potential cases are.

CDC has grown the COVID-19 virus in cell culture, which is necessary for further studies, including for additional genetic characterization. The cell-grown virus was sent to NIH’s BEI Resources Repositoryexternal icon for use by the broad scientific community.

CDC also is developing a serology test for COVID-19.

CDC Recommends

Everyone can do their part to help us respond to this emerging public health threat:

Individuals and communities should familiarize themselves with recommendations to protect themselves and their communities from getting and spreading respiratory illnesses like COVID-19.

Older people and people with severe chronic conditions should take special precautions because they are at higher risk of developing serious COVID-19 illness.

If you are a healthcare provider, use your judgment to determine if a patient has signs and symptoms compatible with COVID-19 and whether the patient should be tested. Factors to consider in addition to clinical symptoms may include:

Does the patient have recent travel from an affected area?

Has the patient been in close contact with someone with COVID-19 or with patients with pneumonia of unknown cause?

Does the patient reside in an area where there has been community spread of COVID-19?

If you are a healthcare provider or a public health responder caring for a COVID-19 patient, please take care of yourself and follow recommended infection control procedures.

If you are a close contact of someone with COVID-19 and develop symptoms of COVID-19, call your healthcare provider and tell them about your symptoms and your exposure. They will decide whether you need to be tested, but keep in mind that there is no treatment for COVID-19 and people who are mildly ill are able to isolate at home.

If you are a resident in a community where there is ongoing spread of COVID-19 and you develop COVID-19 symptoms, call your healthcare provider and tell them about your symptoms. They will decide whether you need to be tested, but keep in mind that there is no treatment for COVID-19 and people who are mildly ill are able to isolate at home.

For people who are ill with COVID-19, but are not sick enough to be hospitalized, please follow CDC guidance on how to reduce the risk of spreading your illness to others. People who are mildly ill with COVID-19 are able to isolate at home during their illness.

If you have been in China or another affected area or have been exposed to someone sick with COVID-19 in the last 14 days, you will face some limitations on your movement and activity. Please follow instructions during this time. Your cooperation is integral to the ongoing public health response to try to slow spread of this virus.

Other Available Resources

The following resources are available with information on COVID-19

World Health Organization, Coronavirusexternal icon

0 notes

vsplusonline · 5 years

Text

Saskatchewan lab joins global effort to develop coronavirus vaccine

New Post has been published on https://apzweb.com/saskatchewan-lab-joins-global-effort-to-develop-coronavirus-vaccine/

Saskatchewan lab joins global effort to develop coronavirus vaccine

SASKATOON — As Canadian public health agencies prepare to deal with a new viral illness, a specialized lab in Saskatoon is using its research on different strains of the coronavirus to help develop a vaccine.

The University of Saskatchewan’s Vaccine and Infectious Disease Organization-International Vaccine Centre, also known as VIDO-InterVac, has received permission from the Public Health Agency of Canada to focus on the threat.

“People need to work together and collaborate and share the information,” said its executive director, Volker Gerdts.

The deadly coronavirus, first linked to a market in the central Chinese city of Wuhan, has been connected to 26 deaths and infections in hundreds of people. South Korea, Japan, Taiwan, Thailand and the United States have each reported at least one case of the virus.

There have been no confirmed cases in Canada and officials say the risk of an outbreak remains low.

About five or six people in Canada are being monitored, including those with a travel history to the Wuhan area and with symptoms of the illness. Respiratory samples are being sent to the National Microbiology Lab in Winnipeg.

“Emerging diseases arrive and, because of all the travel we do and the connectiveness we have right now, the world becomes smaller and smaller and there’s a better chance for these pathogens to quickly spread around the globe,” Gerdts said.

The Saskatchewan lab was developed in the wake of the Severe Acute Respiratory Syndrome, or SARS, outbreak in 2003 to ensure that Canada could be prepared for emerging disease and illness, he added.

Researchers there have spent a significant amount of time focusing on pathogens like coronaviruses. Gerdts said they’ve successfully developed a vaccine for coronavirus strains in cattle and pigs.

“We have expertise in working with them.”

While coronaviruses are relatively small, they are known for mutating and jumping species, which is why they cause so many problems.

Gerdts explained the coronavirus strain in pigs had not been seen in North America until two years ago. But within a year it had affected 10 million of the animals.

Colleagues in China have made the outbreak-specific coronavirus genome sequence available to researchers around the world, Gerdts said. His lab is now using it to hopefully find a way to help.

The lab also has clearance to handle samples of the pathogen and is attempting to get samples from China or the U.S. If that’s not possible, it will order synthetic gene fragments.

The goal is to have the first vaccine candidates ready for testing in animals within six to eight weeks, Gerdts said. But human trials are at least a year away.

Gerdts said Canada has shown a leading role in developing vaccines, including one for the Ebola virus, and there’s a need to have more capacity to manufacture them here.

If his lab had a manufacturing facility that he’s been advocating for, he said production of a coronavirus vaccine for human testing could happen quicker.

Theresa Tam, Canada’s chief public health officer, said Canadian research is part of a global effort and will be shared with the World Health Organization.

“We currently do not have a specific vaccine against this novel coronavirus,” she said. “With a global effort on preparedness, I think that’s something that we need to strive for.”

This report by The Canadian Press was first published Jan. 24, 2020.

Source link

#Health

0 notes

bangkokjacknews · 5 years

Text

What do we know about the DEADLY CORONAVIRUS?

0 notes

rootindiahealthcare · 5 years

Text

Coronavirus Outbreak: 2236 Death & 75000 Still fighting

The new data give the country the most largest number of confirmed reported outside mainland China. 21st Feb 2020: The Chinese officials declared on Friday that there were 889. And these are fresh cases of the coronavirus In the 24 hours. Spreading overall total to more than 75,000. The death toll there went up from 118, to 2236. January 24, 2020 - News about the outbreak of coronavirus that began in Wuhan, China is changing rapidly. Respiratory infection, which is closely associated with SARS; and MERS, is spreading throughout China, and cases have been diagnosed in several other countries, including the United States. We provide cases, deaths, travel restrictions and other latest updates here. What's the latest news? On 29/Jan/2020, Wednesday, CDC medical officials and others met with a group of about 210 US citizens abandoned from China. His plane landed at California's March Air Reserve Base, where an evacuation would be monitored for several days for coronavirus symptoms. Anyone showing signs of the disease; will be taken to the hospital. Some airlines, including British Airways and United Airlines, are halting or reducing flights to China as the number of cases is increasing rapidly. According to the European Center for Disease Prevention and Control. There are now more than 6,000 cases and 132 deaths worldwide. While the majority of cases are in China. It has been found in the US and these countries: Thailand, Hong Kong, Taiwan, Australia, Macau, Singapore, Japan, South Korea, Malaysia, France, Canada, Vietnam, Nepal, Cambodia, Germany, and the United Arab Emirates Emirates. There have been no deaths outside China. USA Alert In the US, the CDC is listing five confirmed cases from these states: Illinois, California, Washington, and Arizona. On Monday, Jan-27-2020, Nancy Massonier, MD, the agency's director of national immunization and respiratory diseases, said it had 165 individuals from 36 states under investigation for coronavirus. In addition to 5 confirmed positives, 68 have tested negative. They are prioritizing testing based on an individual's risk. Massonier said he had posted the blueprint of his clinical trial to a public server; and was working "as soon as possible" to bring the test kit to the states. Right now! all testing for the new coronavirus is being done at the CDC headquarters in Atlanta. She said the CDC is making changes to its travel screening for infection, but did not provide further details. How many people have been treated with the virus? and how many have expired? According to the European CDC, the majority of confirmed cases - 5,994 - are in China. 78 other cases have been confirmed in 16 countries outside China. The most confirmed countries include Thailand with 14 and Taiwan and South Korea with 8. All reported deaths have occurred in China, and include 16 health workers. When did its outbreak begin? China first reported an outbreak in Wuhan on December 30, 2019. What are public officials doing to stop the virus? On Tuesday, the CDC urged passengers to avoid non-essential travel to China. Chinese authorities have shut down all public transport in 10 cities, affecting 35 million people. The first was Wuhan, which had a population of about 11 million. Wuhan, which includes buses, subways, trains, and airports. All passengers flying from Wuhan to the United States will be routed through one of the five airports; and screened for fever and other symptoms of the virus. “Concern patients will be sent to a facility followed by a given a test to find out if they have the virus. What do we know about cases in the United States? In all of the US, cases reported so far, patients had recently traveled to Wuhan. There are two patients in California, one in Los Angeles County and one in Orange County. The Orange County patient is a man in his 50s. According to the Orange County Health Care Agency, she is in a local hospital in isolation and is in good condition. Los Angeles County officials did not provide additional information about the patient there. Arizona's Department of Health Services said its patient is a resident of Maricopa County and a member of the Arizona State University community that did not live in student housing. The patient is not seriously ill and is being kept in isolation. #Chicago Another case involves a 60s-old woman from Chicago. The Chicago Department of Public Health reported that he visited Wuhan, China in December and returned to Chicago earlier this month. He is hospitalized in stable condition. A first American patient is a man in his 30s from Washington state. He had traveled from Wuhan and entered the country before the screening. And He started having symptoms and contacted his doctor. He is in good health and is in quarantine at Providence Regional Medical Center. Is travel to China safe? Wuhan is closed to travelers. The CDC is advising travelers to avoid non-essential travel to China. Passengers required to: Avoid contact with sick people. Avoid animals, animal markets and animal products. Wash your hands often with soap and water, or use an alcohol-based sanitizer if it is not available. Seek immediate medical care for fever, cough or difficulty in breathing. Tell a health care professional about any visit. What are the symptoms; and how is the virus treated further? China performed a test for the virus and shared that information with other nations. The CDC has developed its own test. Symptoms include fever, cough, and shortness of breath. They can appear 2 to 14 days after you are exposed to the virus. What is the cause of the virus, and how does it develop? Health officials are not yet sure of the source of the virus or how easily it can spread. Coronaviruses are discovered in many different animals, including cattle, cats, camels, and bats. A research paper also suggested snakes as a possible source. The new virus may be linked to seafood and live animal market in Wuhan; that has since closed The virus can spread from one infected person to another healthy person. Health officials are seeing this most often where people are close together and in healthcare settings. 16 health care workers have been infected as yet. The CDC believes that severe acute respiratory syndrome (SARS); and the Middle East respiratory syndrome (MERS), two other types of coronavirus; are spread by droplets when someone coughs or sneezes. Is there a comment? There is no vaccine; but the National Institutes of Health is working on one; and the trial is expected to begin in several months. This test will be for safety. If it is safe, then there will be tests to see; how well it works. How to Treat? There is no specific treatment for the virus. The Patients are usually given supportive care with their symptoms; Such as fluids and pain relievers. Hospitalized patients may require breathing assistance. Read the full article

0 notes

ahila-blog1 · 6 years

Text

Global Veterinary Anti-infectives Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Anti-infectives are the substances which have the ability to counter the malfunction caused by foreign bacteria, fungi, virus, parasites, and among others. Anti-infectives are used to prevent or completely cure of various infectious diseases. These substances prevent the chances of contracting the infection by making the body immune from the specific bacterial infection. Commonly occurred veterinary infectious diseases include zoonotic diseases and foodborne disorders.

Increase in the global animal adoption rate, a rise in the prevalence of foodborne and zoonotic diseases, increase in the R&D activities for innovation of new products, and government initiations for the animal healthcare are anticipated to fuel the veterinary anti-infectives market. Moreover, increase in the preference for healthy meat and other dairy products, a rise in awareness about the animal infectious diseases, lack of awareness about veterinary vaccines, and growing animal healthcare expenditure expected to boost the veterinary anti-infectives market over the forecast period. However, stringent regulatory policies for veterinary medicines and lack of awareness about the anti-infective drugs in underdeveloped regions might hinder the growth of veterinary anti-infectives market.

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-veterinary-anti-infectives-market/#ulp-4H8Z4LpNMLEuOnnx

Veterinary anti-infectives market is segmented on the basis of drug type, disease type, species type, route of administration and end user

Based on the drug type, veterinary anti-infectives market is segmented into the following:

· Anti-viral drugs

· Anti-bacterial drugs

· Parasiticides

· Anti-fungal drugs

· Others

Based on the disease type, veterinary anti-infectives market is segmented into the following:

· Dermatological infections

· Respiratory infections

· Gastrointestinal infections

· Ophthalmic infections

· Others

Based on the species type, veterinary anti-infectives market is segmented into the following:

· Farm animals

o Cattle

o Aqua

o Swine

o Sheep

o Poultry

o Others

· Companion animals

o Canines

o Felines

o Horses

o Rabbits

o Others

Based on the route of administration, veterinary anti-infectives market is segmented into the following:

· Oral

· Parenteral

· Topical

· Others

Based on the distribution channel, veterinary anti-infectives market is segmented into the following:

· Veterinary hospitals

· Veterinary pharmacies

· Online pharmacies

· Others

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-veterinary-anti-infectives-market/#ulp-c654SbFYO64MsOhu

The veterinary anti-invectives market is growing at a significant CAGR owing to increase in the animal adoption rate. Market players are actively focusing on the development of novel medicines and vaccines for the prevention or cure of various infectious diseases in animals. The rise in the prevalence of foodborne and zoonotic diseases also expected to propel the veterinary anti-infectives market over the forecast period. Acquisitions and mergers, collaborations, product innovations, and launchings are the strategies followed by the companies for garnering market revenue share in the global veterinary anti-infectives market. For instance, in January 2013, Bayer healthcare acquired Teva’s animal healthcare business including the veterinary anti-infectives for diversifying its veterinary anti-infectives product portfolio. Moreover, In May 2013, Novabay Pharmaceuticals inked a collaboration agreement with Virbac for exploring uses of veterinary anti-infective drug auriclosene.

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-veterinary-anti-infectives-market/#ulp-14mlyhjMGhVjZqa3

Geographically, veterinary anti-infectives market is segmented into Europe, Asia Pacific, Latin America, North America, and the Middle East and Africa. Increase in the pet animal adoption rate, a rise in animal welfare, growing R&D activities for innovation of novel products, and rise in per capita income are the factors anticipated to fuel the veterinary anti-infectives market in North America region. Europe holds a significant share in the veterinary anti-infectives market owing to rise in prevalence of zoonotic and foodborne diseases, innovation of newer products, a rise in awareness the animal welfare, and animal healthcare expenditure are anticipated to fuel the market in the region. However, the Asia Pacific region has a significant growth over the forecast period due to rise in the rearing of farm animals majorly in India and China, increase in the preference for healthy meat and other dairy products, and rise in the prevalence of infectious diseases are anticipated to fuel the veterinary anti-infectives market.

Some of the players in veterinary anti-infectives market are Zoetis, Inc. (Pfizer) (U.S), Virbac AH Inc. (France), Sanofi S.A. (France), Boehringer Ingelheim Vetmedica, Inc. (Boehringer Ingelheim) (Germany), Bayer HealthCare LLC, (Bayer AG) (Germany), Merck Animal Health (Merck &co. Inc.) (U.S.), Dechra Pharmaceuticals (U.K.), and NovaBay Pharmaceuticals, Inc. (U.S.) to name a few.

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-veterinary-anti-infectives-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: [email protected]

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

#Veterinary Anti-infectives Market

0 notes

marketdataforecastblog-blog · 7 years

Text

Animal Healthcare Market – A Scottish View

Scotland Animal Healthcare Market – Overview

The Kansa City Animal Health Corridor is quite well known among those keeping a tab on the animal health care market. The Kansas corridor is the epicenter of all the organizations related to healthcare in North America, accounting for greater than 80 percent of the revenue generated in animal healthcare in North America annually. The corridor functions by providing the interested stake holders with a common ground for interaction and collaboration with top notch market/industry leaders which aids in the growth of the company. The above is an example from North America, but on the same lines, similar developments are taking place in the country of Scotland to translate it into a hub of healthcare for animals in Europe.

The building blocks to help make Scotland the ideal center for aquaculture research and animal healthcare have already been laid. The demographics of the country also aid in the process as about 50 percent of the spending on veterinary healthcare of the United Kingdom if being offered to Scotland. Furthermore, the ample availability of natural for the prospering of the industry is one of the major factors for the choice of Scotland to be established as the European epicenter for veterinary health care. The Roslin Institute has helped in generating annual profits of more than £250 million in the arenas of genetic and breeding research. Also, there are more than a thousand researchers in the country working on the innovation of the veterinary healthcare industry. Vaccines used for the immunization of respiratory problems in sheep and cattle were first created in Scotland. The high availability of skilled labor, good infrastructure and rapid innovation in R&D are the major factors, which, coupled with the steps being taken by the Scottish government, are expected to yield positive results in establishing Scotland as the hub for animal health care in Europe.

There are quite a number of world renowned companies in the animal healthcare industry in Scotland. The Fish Vet Group, which is a subsidiary of Benchmark Holdings, is one of them. The Fish Vet Group has begun operations on a fish farm in the coastal areas of Scotland and has now robustly expanded into a global leader of health services for aquatic animals. Favorable demographics offered by the country have surely aided the company in its journey onward to become a global leader in the market. Furthermore, Veterinary diagnostics, healthcare, and environmental aspect control are among a few services offered by the company. Recently, the company was in the news for the launch of its operations in Thailand, which is one of the largest aquaculture markets on the planet. Top notch researchers are being attracted to work for the company to innovate and further its operations. The world renowned Salmonid Specialist Dr. Marian McLoughlin, is among the latest minds to join the company, which speaks a lot about the brand of the company. The company also acquired Vet Aqua International, which is an Ireland based company, which has further established their position in the market. The company’s presence has now expanded to Ireland, Thailand, Norway, and the USA, all of which are seasoned markets which will undoubtedly aid the company in furthering its ambitions.

One of the major factors which aided the global growth of The Fish Vet Group was the very supportive government policies which provided the required resources for the company to grow and even acquire other market players. Keeping in mind the increasing demand pressures in the veterinary healthcare market it can be concluded that Scotland is one of the growing hotspots of animal health care in the world. The case study of The Fish Vet group can act as example for other market players to launch their business operations in the country.

Check out Market Data Forecast’s comprehensive reports with in-depth analysis about the Europe Veterinary Healthcare Market a free research sample can also be availed. Stay tuned for trending news stories about the latest technologies and interesting Healthcare tit-bits.

#animal healthcare

0 notes

healthy-insights · 7 years

Text

Cattle Biologics Manufacturing Market Growth, Trends and Forecast up to 2020

Cattle biologics are defined as the vaccines, bacterins, diagnostics etc which helps to prevent, diagnose or treat the disease conditions in cattle and calves. These product works through some immunological pathway. The Cattle Biologics Manufacturing Market consist of four major segments on the basis of the products namely Vaccines, Pre-breeding vaccines for calves, Antibodies, Diagnostic kits.

Among these categories, vaccines and pre-breeding vaccines for calves capture the major share of the market. Vaccines are provided to both cattle and calves, especially the new born calves to save them from various diseases such as clostridial diseases, anthrax, bovine virus diarrhea and vibriosis. On the basis of type of manufacturing the cattle biologics manufacturing market is divided into four main categories which includes Bacterins, Bacterin Toxoid, Non-bacterins, Custom made Vaccines.

Bacterins include vaccines which are made from killed bacteria, while the bacterin toxoids include vaccines which are made from live bacteria. In cattle vaccination, bacterin toxoid is preferred over other vaccination due to its long lasting effect. Texas Vet Lab, Inc. is one of the major market players of bacterins and bacterin toxoid and it is offering a wide range of products in its portfolio such as moraxella ovis, unique serovars of Salmonella and Histophilus Somni. Custom-made vaccines are also capturing a major part of the cattle biologics manufacturing market and have been complement to “off-the-shell” products in the U.S. market. Custom-made vaccines are the vaccines which are manufactured from the specific virus or bacteria which is major cause of disease in livestock operation. Newport Laboratories is one of the market players which is offering custom-made vaccines to the producers and veterinarians which gives them option to prepare a mixture of different products, modified according to producer that is not commercially available.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3608

Pre-breeding vaccination includes the vaccines, which are given to calves at the age between 12 months to 15 months. These vaccines are provided to calves to protect them against common reproductive diseases. On the basis of the vaccines which are provided to the calves, cattle biologics manufacturing market is divided into six major classes are Bovine Viral Diarrhea (BVD), Infectious Bovine Rhinotracheitis (IBR), Leptospirosis, Bovine respiratory syncytial virus (BRSV), Clostridium, Trichomoniasis.

Among these the bovine viral diarrhea is most commonly used vaccine followed by leptospirosis and trichomoniasis. All these pre-breeding vaccinations protect calves from delayed breeding, smaller calves, potential abortions and persistently infected calves.

North America and Europe currently lead the cattle biologics manufacturing market majorly due to strong economic conditions and large number of cattle population. The major market of Europe is driven by Switzerland, which is known for cows and cattle. In 2010, there were 1,591, 233 cattle in Switzerland. Additionally, the government of U.S. and Europe has also setup some regulatory firms which are also helping the market to grow. As in Canada, the Canadian Food Inspection Agency (CFIA) regulates veterinary biologics and animal health products such as antibody products, vaccines, diagnostic kits that are used for the prevention, treatment and diagnosis of infectious diseases in animals.

Other major market players in cattle biologics market include Addison Cattle Corporation, Agrilabs, Biocor Animal Health, Inc., Boehringer Ingelheim, Colorado Serum Company, Durvet, Inc., Fort Dodge Animal Health, Merial, Novartis AG and Pfizer, Inc.

Pre-Book Full Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=3608&ltype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com

0 notes